Stay updated on Topical BMX-010 in Skin Diseases Clinical Trial
Sign up to get notified when there's something new on the Topical BMX-010 in Skin Diseases Clinical Trial page.

Latest updates to the Topical BMX-010 in Skin Diseases Clinical Trial page
- Check6 days agoChange DetectedRevision: v3.4.3 is now displayed, replacing Revision: v3.4.2. This appears to be a minor site version update with no changes to study details.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedRemoved related topics for Atopic Dermatitis and MedlinePlus Genetics from the related topics section.SummaryDifference0.2%

- Check34 days agoChange DetectedRevision: v3.4.2 is now shown, and the funding-lapse notice and Revision: v3.4.1 have been removed.SummaryDifference0.4%

- Check41 days agoChange DetectedAdded a site-wide government funding/operating status notice and updated the page revision to v3.4.1 (from v3.4.0).SummaryDifference0.4%

- Check48 days agoChange DetectedThe page now shows a glossary toggle and updated metadata labels (Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0), while corresponding previous labels/texts were removed or altered (Last Update Submitted that met QC Criteria, No FEAR Act data, Revision: v3.3.4). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check62 days agoChange DetectedThe update is a minor revision change from v3.3.3 to v3.3.4 in the site footer, with no changes to the study details or core content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Topical BMX-010 in Skin Diseases Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Topical BMX-010 in Skin Diseases Clinical Trial page.